Skip to main content
Top
Published in: Supportive Care in Cancer 5/2020

01-05-2020 | Erectile Dysfunction | Original Article

Quality improvement in sexual health care for oncology patients: a Canadian multidisciplinary clinic experience

Authors: Adele Duimering, Lauren M. Walker, Jill Turner, Elisha Andrews-Lepine, Amy Driga, Ashley Ayume, John W. Robinson, Ericka Wiebe

Published in: Supportive Care in Cancer | Issue 5/2020

Login to get access

Abstract

Purpose

With the goal of improving the quality of sexual health care provision at our tertiary cancer centre, we developed, implemented, and assessed a multidisciplinary sexuality in an oncology program, to identify patient needs and apply interventions that could be effective in a broader oncology care context.

Methods

The establishment of our institution’s first oncology-focused sexual health program is described within a quality improvement framework. A complementary retrospective chart review was performed to evaluate clinicodemographic data, including responses to validated sexual health questionnaires, from a 2-year clinical pilot.

Results

A sexual health program was introduced for cancer patients identified by health care providers or self-referred, receiving 130 referrals and conducting 64 consultation and 75 follow-up visits within a 2-year pilot period. Patients attending the program were 75% female, of mean age 52 years, and had most often breast (33%) or hematologic (30%) malignancies. Most (84%) had completed curative-intent treatment, with no evidence of disease, with 34% on ongoing endocrine therapy. The most frequent reasons for referral were sexual pain (38%), decreased libido (35%), and vaginal dryness (35% of females). All female patients demonstrated sexual dysfunction on the Female Sexual Function Index, and 80% of male patients demonstrated moderate to severe erectile dysfunction on the Sexual Health Inventory for Men. Patients waited a median of 63 days (SD 107, range 3–516) from referral to consultation, suggesting that demand for multidisciplinary sexual health care overwhelmed existing resources.

Conclusions

We have demonstrated unmet sexual health needs across a diverse oncology patient population and have presented a framework for addressing these issues, highlighting the challenges encountered and proposing improvements. Insights emerging from a quality improvement perspective included the role of group-based sexual health support to improve accessibility and the need for staff education to encourage proactive intervention before referral for specialized care is needed.
Literature
1.
go back to reference Ananth H, Jones L, King M, Tookman A (2003) The impact of cancer on sexual function: a controlled study. Palliat Med 17(2):202–205CrossRef Ananth H, Jones L, King M, Tookman A (2003) The impact of cancer on sexual function: a controlled study. Palliat Med 17(2):202–205CrossRef
2.
go back to reference Ussher J, Perz J, Gilbert E et al (2015) Perceived causes and consequences of sexual changes after cancer for women and men: a mixed method study. BMC Cancer 15:268–285CrossRef Ussher J, Perz J, Gilbert E et al (2015) Perceived causes and consequences of sexual changes after cancer for women and men: a mixed method study. BMC Cancer 15:268–285CrossRef
3.
go back to reference Park E, Norris R, Bober S (2009) Sexual health communication during cancer care. Cancer J 15(1):74–77CrossRef Park E, Norris R, Bober S (2009) Sexual health communication during cancer care. Cancer J 15(1):74–77CrossRef
4.
go back to reference Hautamaki K, Miettinen M, Kellokumpu-Lehtinen P et al (2007) Opening communication with cancer patients about sexuality-related issues. Cancer Nurs 30(5):399–404CrossRef Hautamaki K, Miettinen M, Kellokumpu-Lehtinen P et al (2007) Opening communication with cancer patients about sexuality-related issues. Cancer Nurs 30(5):399–404CrossRef
5.
go back to reference Hill E, Sandbo S, Abramsohn E et al (2011) Assessing gynecologic and breast cancer survivors’ sexual health care needs. Cancer. 117(2):2643–2651CrossRef Hill E, Sandbo S, Abramsohn E et al (2011) Assessing gynecologic and breast cancer survivors’ sexual health care needs. Cancer. 117(2):2643–2651CrossRef
6.
go back to reference Scanlon M, Blaes A, Geller M, Majhail NS, Lindgren B, Haddad T (2012) Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among premenopausal women with cancer. J Cancer 3:217–225CrossRef Scanlon M, Blaes A, Geller M, Majhail NS, Lindgren B, Haddad T (2012) Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among premenopausal women with cancer. J Cancer 3:217–225CrossRef
7.
go back to reference Belbeck A. If sex sells, then are we doing this all wrong? Sexual health and oncology. Oral session presented at Alberta College of Medical Diagnostic & Therapeutic Technologists, Alberta Health Services Annual Conference; April 2013; Edmonton, AB Belbeck A. If sex sells, then are we doing this all wrong? Sexual health and oncology. Oral session presented at Alberta College of Medical Diagnostic & Therapeutic Technologists, Alberta Health Services Annual Conference; April 2013; Edmonton, AB
8.
go back to reference Vermeer W, Bakker R, Kenter G et al (2014) Sexual issues among cervical cancer survivors: how can we help women seek help? Psycho-Oncology 24(4):458–464CrossRef Vermeer W, Bakker R, Kenter G et al (2014) Sexual issues among cervical cancer survivors: how can we help women seek help? Psycho-Oncology 24(4):458–464CrossRef
9.
go back to reference Rasmusson E, Thomé B (2008) Women’s wishes and need for knowledge concerning sexuality and relationships in connection with gynecological cancer disease. Sex Disabil 26(4):207–218CrossRef Rasmusson E, Thomé B (2008) Women’s wishes and need for knowledge concerning sexuality and relationships in connection with gynecological cancer disease. Sex Disabil 26(4):207–218CrossRef
10.
go back to reference Taylor C, Basen-Engquist K, Shinn E et al (2004) Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 22(5):881–889CrossRef Taylor C, Basen-Engquist K, Shinn E et al (2004) Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 22(5):881–889CrossRef
11.
go back to reference Keller A, McGarvey E, Clayton A (2006) Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14). J Sex Marital Ther. 32(1):43–52CrossRef Keller A, McGarvey E, Clayton A (2006) Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14). J Sex Marital Ther. 32(1):43–52CrossRef
12.
go back to reference Derogatis L, Rosen R, Leiblum S et al (2002) The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 28(4):317–330CrossRef Derogatis L, Rosen R, Leiblum S et al (2002) The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 28(4):317–330CrossRef
13.
go back to reference Derogatis L, Clayton A, Lewis-D’Agostino D et al (2008) Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 5(2):357–364CrossRef Derogatis L, Clayton A, Lewis-D’Agostino D et al (2008) Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 5(2):357–364CrossRef
14.
go back to reference Rosen R, Brown C, Heiman J et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208CrossRef Rosen R, Brown C, Heiman J et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208CrossRef
15.
go back to reference Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 31(1):1–20CrossRef Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 31(1):1–20CrossRef
17.
go back to reference Weiner L, Cannon N, Avery-Clark C (2014) Reclaiming the lost art of sensate focus: a clinician’s guide. Family Therapy Magazine 13(5):46–48 Weiner L, Cannon N, Avery-Clark C (2014) Reclaiming the lost art of sensate focus: a clinician’s guide. Family Therapy Magazine 13(5):46–48
18.
go back to reference Bober S, Reese J, Barbera L et al (2016) How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care 10(1):44–54CrossRef Bober S, Reese J, Barbera L et al (2016) How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care 10(1):44–54CrossRef
19.
go back to reference Barbera L, Zwaal C, Elterman D, McPherson K, Wolfman W, Katz A, Matthew A (2017) Interventions to address sexual problems in people with cancer. Curr Oncol 24(3):192–200CrossRef Barbera L, Zwaal C, Elterman D, McPherson K, Wolfman W, Katz A, Matthew A (2017) Interventions to address sexual problems in people with cancer. Curr Oncol 24(3):192–200CrossRef
20.
go back to reference Walker L, Villiger M, Robinson J (2018) Assessing the utility of a distress screening tool at capturing sexual concerns in a gyne-oncology follow-up clinic. Support Care Cancer 26(3):887–893CrossRef Walker L, Villiger M, Robinson J (2018) Assessing the utility of a distress screening tool at capturing sexual concerns in a gyne-oncology follow-up clinic. Support Care Cancer 26(3):887–893CrossRef
22.
go back to reference Leung M, Goldfarb S, Dizon D (2016) Communication about sexuality in advanced illness aligns with a palliative care approach to patient-centred care. Curr Oncol Rep 18(2):11–16CrossRef Leung M, Goldfarb S, Dizon D (2016) Communication about sexuality in advanced illness aligns with a palliative care approach to patient-centred care. Curr Oncol Rep 18(2):11–16CrossRef
23.
go back to reference McKee A, Schover L (2001) Sexuality rehabilitation. Cancer. 92(54):1008–1012CrossRef McKee A, Schover L (2001) Sexuality rehabilitation. Cancer. 92(54):1008–1012CrossRef
24.
go back to reference Kotronoulas G, Papadopoulou C, Patiraki E (2009) Nurses’ knowledge, attitudes, and practices regarding provision of sexual health care in patients with cancer: critical review of the evidence. Support Care Cancer 17(5):479–501CrossRef Kotronoulas G, Papadopoulou C, Patiraki E (2009) Nurses’ knowledge, attitudes, and practices regarding provision of sexual health care in patients with cancer: critical review of the evidence. Support Care Cancer 17(5):479–501CrossRef
25.
go back to reference Julien J, Thom B, Kline N (2010) Identification of barriers to sexual health assessment in oncology nursing practice. Oncol Nurs Forum 37(3):E186–E190CrossRef Julien J, Thom B, Kline N (2010) Identification of barriers to sexual health assessment in oncology nursing practice. Oncol Nurs Forum 37(3):E186–E190CrossRef
26.
go back to reference Stead M, Brown J, Fallowfield L et al (2003) Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer 88(5):666–671CrossRef Stead M, Brown J, Fallowfield L et al (2003) Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer 88(5):666–671CrossRef
27.
go back to reference Fitch M, Beaudoin G, Johnson B (2013) Challenges having conversations about sexuality in ambulatory settings: part II – health care provider perspectives. Can Oncol Nurs J 23(3):182–196CrossRef Fitch M, Beaudoin G, Johnson B (2013) Challenges having conversations about sexuality in ambulatory settings: part II – health care provider perspectives. Can Oncol Nurs J 23(3):182–196CrossRef
28.
go back to reference Wiggins D, Wood R, Granai C et al (2007) Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO). J Psychosoc Oncol 25(4):61–70CrossRef Wiggins D, Wood R, Granai C et al (2007) Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO). J Psychosoc Oncol 25(4):61–70CrossRef
29.
go back to reference McCallum M, Jolicoeur L, Lefebvre M, Babchishin LK, Robert-Chauret S, le T, Lebel S (2014) Supportive care needs after gynecologic cancer: where does sexual health fit in? Oncol Nurs Forum 41(3):297–306CrossRef McCallum M, Jolicoeur L, Lefebvre M, Babchishin LK, Robert-Chauret S, le T, Lebel S (2014) Supportive care needs after gynecologic cancer: where does sexual health fit in? Oncol Nurs Forum 41(3):297–306CrossRef
30.
go back to reference McCallum M, Lefebvre M, Jolicoeur L, Maheu C, Lebel S (2012) Sexual health and gynecological cancer: conceptualizing patient needs and overcoming barriers to seeking and accessing services. J Psychosom Obstet Gynaecol 33(3):135–142CrossRef McCallum M, Lefebvre M, Jolicoeur L, Maheu C, Lebel S (2012) Sexual health and gynecological cancer: conceptualizing patient needs and overcoming barriers to seeking and accessing services. J Psychosom Obstet Gynaecol 33(3):135–142CrossRef
31.
go back to reference Patterson L, Handy A, Brotto L (2017) A pilot study of eight-session mindfulness-based cognitive therapy adapted for women’s sexual interest/arousal disorder. J Sex Res 54(7):850–861CrossRef Patterson L, Handy A, Brotto L (2017) A pilot study of eight-session mindfulness-based cognitive therapy adapted for women’s sexual interest/arousal disorder. J Sex Res 54(7):850–861CrossRef
32.
go back to reference Baumgart J, Nilsson K, Evers A et al (2013) Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 20(2):162–168CrossRef Baumgart J, Nilsson K, Evers A et al (2013) Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 20(2):162–168CrossRef
33.
go back to reference Broeckel J, Thors C, Jacobsen P et al (2002) Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 75(3):241–248CrossRef Broeckel J, Thors C, Jacobsen P et al (2002) Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 75(3):241–248CrossRef
34.
go back to reference Panjari M, Bell R, Davis S (2011) Sexual function after breast cancer. J Sex Med 8(1):294–302CrossRef Panjari M, Bell R, Davis S (2011) Sexual function after breast cancer. J Sex Med 8(1):294–302CrossRef
35.
go back to reference The North American Menopause Society (2017) The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 42(7):728–753 The North American Menopause Society (2017) The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 42(7):728–753
36.
go back to reference American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice, Farrell R (2016) ACOG Committee Opinion No. 659 summary: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol 127(3):e93–e96CrossRef American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice, Farrell R (2016) ACOG Committee Opinion No. 659 summary: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol 127(3):e93–e96CrossRef
37.
go back to reference Stilos K, Doyle C, Daines P (2008) Addressing the sexual health needs of patients with gynecologic cancers. Clin J Oncol Nurs 12(3):457–463CrossRef Stilos K, Doyle C, Daines P (2008) Addressing the sexual health needs of patients with gynecologic cancers. Clin J Oncol Nurs 12(3):457–463CrossRef
38.
go back to reference Barbera L, Fitch M, Adams L, Doyle C, DasGupta T, Blake J (2011) Improving care for women after gynecological cancer: the development of a sexuality clinic. Menopause. 18(12):1327–1333CrossRef Barbera L, Fitch M, Adams L, Doyle C, DasGupta T, Blake J (2011) Improving care for women after gynecological cancer: the development of a sexuality clinic. Menopause. 18(12):1327–1333CrossRef
39.
go back to reference Iavazzo C, Johnson K, Savage H, Gallagher S, Datta M, Winter-Roach BA (2015) Sexuality issues in gynaecological oncology patients: post treatment symptoms and therapeutic options. Arch Gynecol Obstet 291(3):653–656CrossRef Iavazzo C, Johnson K, Savage H, Gallagher S, Datta M, Winter-Roach BA (2015) Sexuality issues in gynaecological oncology patients: post treatment symptoms and therapeutic options. Arch Gynecol Obstet 291(3):653–656CrossRef
40.
go back to reference Matthew A, Lutzky-Cohen N, Jamnicky L et al (2018) The prostate cancer rehabilitation clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy. Curr Oncol 25(6):393–402CrossRef Matthew A, Lutzky-Cohen N, Jamnicky L et al (2018) The prostate cancer rehabilitation clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy. Curr Oncol 25(6):393–402CrossRef
Metadata
Title
Quality improvement in sexual health care for oncology patients: a Canadian multidisciplinary clinic experience
Authors
Adele Duimering
Lauren M. Walker
Jill Turner
Elisha Andrews-Lepine
Amy Driga
Ashley Ayume
John W. Robinson
Ericka Wiebe
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05040-4

Other articles of this Issue 5/2020

Supportive Care in Cancer 5/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine